A meta-analysis of pigmentary characteristics, sun sensitivity, freckling and melanocytic nevi and risk of basal cell carcinoma of the skin

Cancer Epidemiology

Volumn 37, Issue 5, 2013, Pages 534-543

  Khalesi, Mohammad ^a,b,c   Whiteman, David C ^a,c   Tran, Bich ^a,c   Kimlin, Michael G ^b,c   Olsen, Catherine M ^a   Neale, Rachel E ^a,c  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c Centre for Research Excellence in Sun and Health   (Australia)

Author keywords

Basal cell carcinoma; Burning; Eye colour; Freckling; Hair colour; Melanocytic nevi; Meta analysis; Pigmentary; Skin colour; Tanning

Indexed keywords

ADULTHOOD; BASAL CELL CARCINOMA; CANCER RISK; CHILDHOOD; EYE COLOR; HAIR COLOR; HUMAN; LENTIGO; MELANOCYTIC NEVUS; META ANALYSIS; NON MELANOMA SKIN CANCER; PRIORITY JOURNAL; REVIEW; SKIN BURNING SENSATION; SKIN COLOR; SKIN MANIFESTATION; SUN EXPOSURE;

ACTINIC KERATOSES; AK; BASAL CELL CARCINOMA; BCC; BURNING; CI; CONFIDENCE INTERVAL; EYE COLOUR; FRECKLING; HAIR COLOUR; MELANOCYTIC NEVI; META-ANALYSIS; ODDS RATIO; OR; PIGMENTARY; RELATIVE RISK; RR; SCC; SKIN COLOUR; SQUAMOUS CELL CARCINOMA; TANNING; ULTRAVIOLET RADIATION; UVR;

CARCINOMA, BASAL CELL; CASE-CONTROL STUDIES; COHORT STUDIES; HAIR COLOR; HUMANS; MELANOSIS; NEVUS, PIGMENTED; PIGMENTATION; SKIN NEOPLASMS; SKIN PIGMENTATION; SUNBURN;

EID: 84884134953     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2013.05.008     Document Type: Review

References (84)

1. AIHW Cancer in Australia: an Overview 2012. Cancer series no. 74. Cat. no. CAN 70 2012, AIHW, Canberra.
2. Staples M.P., Elwood M., Burton R.C., Williams J.L., Marks R., Giles G.G. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 2006, 184(1):6-10.
3. Brewster D.H., Bhatti L.A., Inglis J.H., Nairn E.R., Doherty V.R. Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland: 1992-2003. Br J Dermatol 2007, 156(6):1295-1300.
4. Stang A., Ziegler S., Buchner U., Ziegler B., Jockel K.H., Ziegler V. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach. Int J Dermatol 2007, 46(6):564-570.
5. Birch-Johansen F., Jensen A., Mortensen L., Olesen A.B., Kjaer S.K. Trends in the incidence of nonmelanoma skin cancer in Denmark 1978-2007: rapid incidence increase among young Danish women. Int J Cancer 2010, 127(9):2190-2198.
6. Lipozencic J., Celic D., Strnad M., Toncic R.J., Pasic A., Rados J., et al. Skin cancers in Croatia, 2003-2005: epidemiological study. Coll Antropol 2010, 34(3):865-869.
7. Flohil S.C., de Vries E., Neumann H.A., Coebergh J.W., Nijsten T. Incidence: prevalence and future trends of primary basal cell carcinoma in the Netherlands. Acta Derm Venereol 2011, 91(1):24-30.
8. Bath-Hextall F., Leonardi-Bee J., Smith C., Meal A., Hubbard R. Trends in incidence of skin basal cell carcinoma. Additional evidence from a UK primary care database study. Int J Cancer 2007, 121(9):2105-2108.
9. Demers A.A., Nugent Z., Mihalcioiu C., Wiseman M.C., Kliewer E.V. Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population. J Am Acad Dermatol 2005, 53(2):320-328.
10. Jung G.W., Metelitsa A.I., Dover D.C., Salopek T.G. Trends in incidence of nonmelanoma skin cancers in Alberta: Canada, 1988-2007. Br J Dermatol 2010, 163(1):146-154.
11. Chuang T.Y., Popescu A., Su W.P., Chute C.G. Basal cell carcinoma. A population-based incidence study in Rochester: Minnesota. J Am Acad Dermatol 1990, 22(3):413-417.
12. Scotto J., Fears T.R., Fraumeni J.F. Incidence of nonmelanoma skin cancer in the United States 1983, US Dept. of Health and Human Services, National Institutes of Health, Bethesda, MD.
13. Reizner G.T., Chuang T.Y., Elpern D.J., Stone J.L., Farmer E.R. Basal cell carcinoma in Kauai, Hawaii: the highest documented incidence in the United States. J Am Acad Dermatol 1993, 29(2 Pt 1):184-189.
14. Harris R.B., Griffith K., Moon T.E. Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona: 1985-1996. J Am Acad Dermatol 2001, 45(4):528-536.
15. Ko C.B., Walton S., Keczkes K., Bury H.P., Nicholson C. The emerging epidemic of skin cancer. Br J Dermatol 1994, 130(3):269-272.
16. Holme S.A., Malinovszky K., Roberts D.L. Changing trends in non-melanoma skin cancer in South Wales: 1988-98. Br J Dermatol 2000, 143(6):1224-1229.
17. Skellett A.M., Hafiji J., Greenberg D.C., Wright K.A., Levell N.J. The incidence of basal cell carcinoma in the under-30s in the UK. Clin Exp Dermatol 2012.
18. Doherty V.R., Brewster D.H., Jensen S., Gorman D. Trends in skin cancer incidence by socioeconomic position in Scotland: 1978-2004. Br J Cancer 2010, 102(11):1661-1664.
19. AIHW Health System Expenditures on Cancer and Other Neoplasms in Australia, 2000-01 2005, Australian Institute of Health and Welfare, cat. no. HWE 29.
20. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of observational studies in epidemiology (MOOSE) group. JAMA 2000, 283(15):2008-2012.
21. Ruiz Lascano A., Kuznitzky R., Garay I., Ducasse C., Albertini R. Risk factors for basal cell carcinoma. Case-control study in Cordoba. Medicina (B Aires) 2005, 65(6):495-500.
22. Sanchez G., Nova J., de la Hoz F. Risk factors for basal cell carcinoma: a study from the National dermatology center of Colombia. Actas Dermosifiliogr 2012, 103(4):294-300.
23. Raznatovic M., Maksimovic N., Jankovic J., Music D. [Impact of some constitutional characteristics on the development of basal cell carcinoma]. Vojnosanit Pregl 2007, 64(6):375-379.
24. Rocha F.P., Menezes A., Almeida Junior H.L., Tomasi E. Risk markers and risk factors for actinic keratosis and basal cell carcinoma: a case-control study. An Bras Dermatol 2004, 79(4):441-454.
25. Healy E., Collins P., Barnes L. Nonmelanoma skin cancer in an Irish population: an appraisal of risk factors. Ir Med J 1995, 88(2):58-59.
26. Ferreira F.R., Nascimento L.F.C., Rotta O. Fatores de risco para câncer da pele não melanoma em Taubaté, SP: um estudo caso-controle. Rev Assoc Med Bras 2011, 57:431-437.
27. Lichte V., Dennenmoser B., Dietz K., Häfner H.M., Schlagenhauff B., Garbe C., et al. Professional risk for skin cancer development in male mountain guides-a cross-sectional study. J Eur Acad Dermatol Venereol 2010, 24(7):797-804.
28. Herity B., O'Loughlin G., Moriarty M.J., Conroy R. Risk factors for non-melanoma skin cancer. Ir Med J 1989, 82(4):151-152.
29. Liboutet M., Portela M., Delestaing G., Vilmer C., Dupin N., Gorin I., et al. MC1R and PTCH gene polymorphism in French patients with basal cell carcinomas. J Invest Dermatol 2006, 126(7):1510-1517.
30. Foote J.A., Harris R.B., Giuliano A.R., Roe D.J., Moon T.E., Cartmel B., et al. Predictors for cutaneous basal- and squamous-cell carcinoma among actinically damaged adults. Int J Cancer 2001, 95(1):7-11.
31. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7(3):177-188.
32. Hardy R.J., Thompson S.G. Detecting and describing heterogeneity in meta-analysis. Stat Med 1998, 17(8):841-856.
33. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21(11):1539-1558.
34. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50(4):1088-1101.
35. Egger M., Smith G.D., Schneider M., Minder C. Bias in meta-analysis detected by a simple: graphical test. BMJ 1997, 315(7109):629-634.
36. Janković S., Maksimović N., Janković J., Ražnatović M., Marinković J., Tomić-Spirić V. Risk factors for basal cell carcinoma: results from the case-control study. Cent Eur J Med 2010, 5(6):666-673.
37. Gellin G.A., Kopf A.W., Garfinkel L. Basal cell epithelioma. A controlled study of associated factors. Arch Dermatol 1965, 91:38-45.
38. Gamble J.F., Lerman S.E., Holder W.R., Nicolich M.J., Yarborough C.M. Physician-based case-control study of non-melanoma skin cancer in Baytown: Texas. Occup Med (Lond) 1996, 46(3):186-196.
39. Gallagher R.P., Hill G.B., Bajdik C.D., Fincham S., Coldman A.J., McLean D.I., et al. Sunlight exposure: pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 1995, 131(2):157-163.
40. Vlajinac H.D., Adanja B.J., Lazar Z.F., Bogavac A.N., Bjekic M.D., Marinkovic J.M., et al. Risk factors for basal cell carcinoma. Acta Oncol 2000, 39(5):611-616.
41. Ferrucci L.M., Cartmel B., Molinaro A.M., Gordon P.B., Leffell D.J., Bale A.E., et al. Host phenotype characteristics and MC1R in relation to early-onset basal cell carcinoma. J Invest Dermatol 2011.
42. Maia M., Proenca N.G., de Moraes J.C. Risk factors for basal cell carcinoma: a case-control study. Rev Saude Publica 1995, 29(1):27-37.
43. Lear J.T., Tan B.B., Smith A.G., Bowers W., Jones P.W., Heagerty A.H., et al. Risk factors for basal cell carcinoma in the UK: case-control study in 806 patients. J R Soc Med 1997, 90(7):371-374.
44. Lock-Andersen J., Drzewiecki K.T., Wulf H.C. Eye and hair colour: skin type and constitutive skin pigmentation as risk factors for basal cell carcinoma and cutaneous malignant melanoma. A Danish case-control study. Acta Derm Venereol 1999, 79(1):74-80.
45. Dessinioti C., Tzannis K., Sypsa V., Nikolaou V., Kypreou K., Antoniou C., et al. Epidemiologic risk factors of basal cell carcinoma development and age at onset in a Southern European population from Greece. Exp Dermatol 2011, 20(8):622-626.
46. Kricker A., Armstrong B.K., English D.R., Heenan P.J. Pigmentary and cutaneous risk factors for non-melanocytic skin cancer-a case-control study. Int J Cancer 1991, 48(5):650-662.
47. Van Dam R.M., Huang Z., Rimm E.B., Weinstock M.A., Spiegelman D., Colditz G.A., et al. Risk factors for basal cell carcinoma of the skin in men: results from the health professionals follow-up study. Am J Epidemiol 1999, 150(5):459-468.
48. Naldi L., DiLandro A., D'Avanzo B., Parazzini F. Host-related and environmental risk factors for cutaneous basal cell carcinoma: evidence from an Italian case-control study. J Am Acad Dermatol 2000, 42(3):446-452.
49. Lock-Andersen J., Drzewiecki K.T., Wulf H.C. Naevi as a risk factor for basal cell carcinoma in Caucasians: a Danish case-control study. Acta Derm Venereol 1999, 79(4):314-319.
50. Qureshi A.A., Zhang M., Han J. Heterogeneity in host risk factors for incident melanoma and non-melanoma skin cancer in a cohort of US women. J Epidemiol 2011, 21(3):197-203.
51. Fariñas-Alvarez C., Ródenas J.M., Herranz M.T.M.D-R. The naevus count on the arms as a predictor of the number of melanocytic naevi on the whole body. Br J Dermatol 1999, 140(3):457-462.
52. English J.S.C., Swerdlow A.J., Mackie R.M., O'Doherty C.J., Hunter J.A.A., Clark J., et al. Site-specific melanocytic naevus counts as predictors of whole body naevi. Br J Dermatol 1988, 118(5):641-644.
53. Rampen F.H., Fleuren B.A., de Boo T.M., Lemmens W.A. Unreliability of self-reported burning tendency and tanning ability. Arch dermatol 1988, 124(6):885-888.
54. Youn J.I., Oh J.K., Kim B.K., Suh D.H., Chung J.H., Oh S.J., et al. Relationship between skin phototype and MED in Korean, brown skin. Photodermatol Photoimmunol Photomed 1997, 13(5-6):208-211.
55. Sanclemente G., Zapata J-F., García J-J., Gaviria Á., Gómez L.-F., Barrera M. Lack of correlation between minimal erythema dose and skin phototype in a colombian scholar population. Skin Res Technol 2008, 14(4):403-409.
56. Valery P.C., Neale R., Williams G., Pandeya N., Siller G., Green A. The effect of skin examination surveys on the incidence of basal cell carcinoma in a Queensland community sample: a 10-year longitudinal study. J Investig Dermatol Symp Proc 2004, 9(2):148-151.
57. Green A., Williams G., Neale R., Hart V., Leslie D., Parsons P., et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 1999, 354(9180):723-729.
58. Heitmann C., Greiser E., Dören M. The impact of the Women's health initiative randomized controlled trial 2002 on perceived risk communication and use of postmenopausal hormone therapy in Germany. Menopause 2005, 12(4):405-411.
59. Falk M., Magnusson H. Sun protection advice mediated by the general practitioner: an effective way to achieve long-term change of behaviour and attitudes related to sun exposure?. Scand J Prim Health Care 2011, 29(3):135-143.
60. Smith B.J., Ferguson C., McKenzie J., Bauman A., Vita P. Impacts from repeated mass media campaigns to promote sun protection in Australia. Health Promot Int 2002, 17(1):51-60.
61. Quéreux G., JNgC M., Jumbou O., Lequeux Y., Dréno B. Validation of the self-assessment of melanoma risk score for a melanoma-targeted screening. Eur J Cancer Prev 2012, Epub ahead of print.
62. Gail M.H., Costantino J.P. Validating and improving models for projecting the absolute risk of breast cancer. J Natl Cancer Inst 2001, 93(5):334-335.
63. Freedman A.N., Slattery M.L., Ballard-Barbash R., Willis G., Cann B.J., Pee D., et al. Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol 2009, 27(5):686-693.
64. Freedman A.N., Seminara D., Gail M.H., Hartge P., Colditz G.A., Ballard-Barbash R., et al. Cancer risk prediction models: a workshop on development, evaluation, and application. J Clin Oncol 2005, 97(10):715-723.
65. Patil V., Wahab S., Zodpey S., Vasudeo N. Development and validation of risk scoring system for prediction of cancer cervix. Indian J Public Health 2006, 50(1):38-42.
66. Wang W., Chen S., Brune K.A., Hruban R.H., Parmigiani G., Klein A.P. PancPRO. Risk assessment for individuals with a family history of pancreatic cancer. J Clin Oncol 2007, 25(11):1417-1422.
67. Wilson P.W.F., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97(18):1837-1847.
68. Stephens J.W., Ambler G., Vallance P., Betteridge D.J., Humphries S.E., Hurel S.J. Cardiovascular risk and diabetes. Are the methods of risk prediction satisfactory?. Eur J Cardiovasc Prev Rehabil 2004, 11(6):521-528.
69. Edwards A., Unigwe S., Elwyn G., Hood K. Effects of communicating individual risks in screening programmes: cochrane systematic review. BMJ 2003, 327(7417):703-709.
70. Burke L.E., Dunbar-jacob J.M., Hill M.N. Compliance with cardiovascular disease prevention strategies: a review of the research. Ann Behav Med 1997, 19(3):239-263.
71. Kiiski V., de Vries E., Flohil S.C., Bijl M.J., Hofman A., Stricker B.H., et al. Risk factors for single and multiple basal cell carcinomas. Arch Dermatol 2010, 146(8):848-855.
72. Green A., Battistutta D., Hart V., Leslie D., Weedon D. Skin cancer in a subtropical Australian population: incidence and lack of association with occupation. The Nambour Study Group. Am J Epidemiol 1996, 144(11):1034-1040.
73. Vitasa B.C., Taylor H.R., Strickland P.T., Rosenthal F.S., West S., Abbey H., et al. Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen. Cancer 1990, 65(12):2811-2817.
74. Dwyer T., Blizzard L., Ashbolt R., Plumb J., Berwick M., Stankovich J.M. Cutaneous melanin density of Caucasians measured by spectrophotometry and risk of malignant melanoma: basal cell carcinoma, and squamous cell carcinoma of the skin. Am J Epidemiol 2002, 155(7):614-621.
75. Rosso S., Joris F., Zanetti R. Risk of basal and squamous cell carcinomas of the skin in Sion, Switzerland: a case-control study. Tumori 1999, 85(6):435-442.
76. Hogan D.J., To T., Gran L., Wong D., Lane P.R. Risk factors for basal cell carcinoma. Int J Dermatol 1989, 28(9):591-594.
77. Gon A., Minelli L. Risk factors for basal cell carcinoma in a southern Brazilian population: a case-control study. Int J Dermatol 2011, 50(10):1286-1290.
78. Walther U., Kron M., Sander S., Sebastian G., Sander R., Peter R.U., et al. Risk and protective factors for sporadic basal cell carcinoma: results of a two-centre case-control study in southern Germany. Clinical actinic elastosis may be a protective factor. Br J Dermatol 2004, 151(1):170-178.
79. Corona R., Dogliotti E., D'Errico M., Sera F., Iavarone I., Baliva G., et al. Risk factors for basal cell carcinoma in a Mediterranean population: role of recreational sun exposure early in life. Arch Dermatol 2001, 137(9):1162-1168.
80. Wei Q., Matanoski G.M., Farmer E.R., Hedayati M.A., Grossman L. DNA repair and aging in basal cell carcinoma: a molecular epidemiology study. Proc Natl Acad Sci U S A 1993, 90(4):1614-1618.
81. Gafa L., Filippazzo M.G., Tumino R., Dardanoni G., Lanzarone F., Dardanoni L. Risk factors of nonmelanoma skin cancer in Ragusa, Sicily: a case-control study. Cancer Causes Control 1991, 2(6):395-399.
82. Friedman-Birnbaum R., Linn S., Eidlitz-Markus T., Harth Y., Cohen E. Seborrheic skin and acne vulgaris as protective factors against the development of basal cell epithelioma. Dermatologica 1991, 183(3):160-163.
83. Vitaliano P.P., Urbach F. The relative importance of risk factors in nonmelanoma carcinoma. Arch Dermatol 1980, 116(4):454-456.
84. Zanetti R., Rosso S., Martinez C., Navarro C., Schraub S., Sancho-Garnier H., et al. The multicentre south European study 'Helios'. I: Skin characteristics and sunburns in basal cell and squamous cell carcinomas of the skin. Br J Cancer 1996, 73(11):1440-1446.